TITLE

The complicated path to true causes of disease: role of nuclear factor κB in inflammatory bowel disease

AUTHOR(S)
Schreiber, S.
PUB. DATE
April 2005
SOURCE
Gut;Apr2005, Vol. 54 Issue 4, p444
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
This article focuses on the role of nuclear factor kappa B (NFkB) in inflammatory bowel disease. NFkB was discovered as a transcription factor some 15 years ago. Since then the protein has been linked to early pathophysiological events in a host of inflammatory conditions. In Crohn's disease, mechanistic data have been generated in an animal model that undoubtedly demonstrated that activation of NFkB is intimately linked to mucosal inflammation and destruction. The use of antisense constructs to silence NFkB greatly improved inflammatory lesions in the murine interleukin 10 knockout model of inflammatory bowel disease (IBD) and also resolved inflammatory events in human intestinal cells from patients with IBD.
ACCESSION #
16556640

 

Related Articles

  • A DOUBLE BLIND, PLACEBO CONTROLLED RANDOMISED TRIAL OF CURCUMIN EXTRACT IN THE TREATMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE. Atkinson, R.J.; Hunter, J.O. // Gut;Apr2003 Supplement 1, Vol. 52, pA63 

    Introduction: Nuclear factor kappa B (NFkB) is a pro-inflammatory transcription factor which plays an integral part in the pathogenesis of inflammatory bowel disease (IBD). Curcumin has anti-inflammatory properties through prevention of NFkB activation and is effective in the TNBS model of...

  • Inflammatory disease: Local therapy for inflammatory bowel disease. Brazil, Melanie // Nature Reviews Drug Discovery;Dec2005, Vol. 4 Issue 12, p958 

    The article reports on the successful treatment of both murine models of ulcerative colitis and Crohn's disease with locally or systematically delivered nuclear factor-;A. The authors showed that intrarectal or intraperitoneal administration of decoy oligodeoxynucleotides, which were...

  • Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis. Visekruna, Alexander; Joeris, Thorsten; Seidel, Daniel; Kroesen, Anjo; Loddenkemper, Christoph; Zeitz, Martin; Kaufmann, Stefan H. E.; Schmidt-Ullrich, Ruth; Steinhoff, Ulrich // Journal of Clinical Investigation;Dec2006, Vol. 116 Issue 12, p3195 

    Enhanced NF-κB activity is involved in the pathology of both forms of inflammatory bowel disease (IBD), Crohn disease (CD) and ulcerative colitis (UC). Here we analyzed the mechanism of proteasome-mediated NF-κB activation in CD and UC. Our studies demonstrate that the subunit composition...

  • The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Moschen, A. R.; Kaser, A.; Enrich, B.; Ludwiczek, O.; Gabriel, M.; Obrist, P.; Wolf, A. M.; Tilg, H. // Gut;Apr2005, Vol. 54 Issue 4, p479 

    Background and aims: A substantial proportion of patients with inflammatory bowel disease (IBD) develops osteopenia and osteoporosis in the course of disease. Recent data from a mouse model of colitis suggest that the receptor activator of nuclear factor kappa B (RANKL)/osteoprotegerin (OPG)...

  • TFT Adds NF-kappa B Decoy Program.  // Bioworld Week;6/9/2008, Vol. 16 Issue 23, p4 

    The article reports that Transcription Factor Therapeutics Inc. (TFT) has considered rights to NF-kappa B Decoy program including a $114 million deal from Anesiva Inc. in Irvine, California. It states that TFT will get intellectual property pertaining to NF-kappa B, a transcription factor that...

  • TLR5 Risk-Associated Haplotype for Canine Inflammatory Bowel Disease Confers Hyper-Responsiveness to Flagellin. Kathrani, Aarti; Holder, Angela; Catchpole, Brian; Alvarez, Lorena; Simpson, Kenneth; Werling, Dirk; Allenspach, Karin // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Single nucleotide polymorphisms (SNP) in the TLR5 gene have been associated with human inflammatory bowel disease (IBD) and animal models of this disease. We recently demonstrated a significant association between three nonsynonymous SNPs in the canine TLR5 gene and IBD in German shepherd dogs...

  • Inflammatory bowel disease II.  // Gut;Jul2012 Supplement, Vol. 61, pA221 

    The article presents abstracts on medical topics of Great Britain which include inflammatory bowel diseases, the activation of Nuclear Factor kappa B and Crohn's disease.

  • Non-viral delivery of nuclear factor-κ decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. De Vry, Christopher G.; Prasad, Srinivasa; Komuves, Laszlo; Lorenzana, Carlos; Parham, Christi; Le, Tina; Adda, Sarvesh; Hoffman, Jennifer; Kahoud, Nicole; Garlapati, Radhika; Shyamsundar, Radha; Mai, Kim; Jie Zhang; Muchamuel, Tony; Dajee, Maya; Schryver, Brian; McEvoy, Leslie M.; Ehrhardt, Rolf O. // Gut;Apr2007, Vol. 56 Issue 4, p524 

    Background: Nuclear factor-κB (NF-κB) is a key transcriptional regulator of inflammatory bowel disease (IBD). Aim: To investigate the therapeutic potential of a locally administered "non-viral" nuclear factor-κB decoy (NFκBD) in multiple experimental models of IBD. Methods: A fully...

  • Activation of NF-κB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients. La Ferla, Katia; Seegert, Dirk; Schreiber, Stefan // International Journal of Colorectal Disease;Jul2004, Vol. 19 Issue 4, p334 

    Background and aims. The involvement of bacteria in the pathogenesis of inflammatory bowel disease has been discussed for several years. In this study we evaluated the ability of E. coli isolates from inflamed and noninflamed colonic mucosa to activate NF-κB. Materials and methods. Fifteen...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics